# ATSF NE Office – FDA Inspection, Mar 7, 2017

Source: https://www.keypedia.com/records/fda_inspections/atsf-ne-office/55460f60-3b64-4da3-87ab-47c11329a139
Source feed: FDA_Inspections

> FDA inspection 1017531 of ATSF NE Office, March 07, 2017. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 1271. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1017531
- Company Name: ATSF NE Office
- Inspection Date: 2017-03-07
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1318880 - 2026-04-21
- FDA Inspection 1170922 - 2022-05-04
- [FDA Inspection 908387 - 2014-12-18](https://www.keypedia.com/records/fda_inspections/atsf-ne-office/d5b0d5c2-0628-4a85-bdae-10de4852d8e3)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/susan-m-north/28518e5b-45b9-4405-a033-baa1cdb1bdc6)

Company: https://www.keypedia.com/companies/atsf-ne-office/09d16c32-1fef-4bd0-abfc-928fcb4a6087

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d